SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001410578-22-000230
Filing Date
2022-02-28
Accepted
2022-02-28 16:43:36
Documents
71
Period of Report
2021-11-30

Document Format Files

Seq Description Document Type Size
1 10-K tmb-20211130x10k.htm   iXBRL 10-K 1810383
2 EX-10.23 tmb-20211130xex10d23.htm EX-10.23 16903
3 EX-31 tmb-20211130xex31.htm EX-31 12910
4 EX-32 tmb-20211130xex32.htm EX-32 5284
  Complete submission text file 0001410578-22-000230.txt   7892667

Data Files

Seq Description Document Type Size
5 EX-101.SCH tmb-20211130.xsd EX-101.SCH 65979
6 EX-101.CAL tmb-20211130_cal.xml EX-101.CAL 33791
7 EX-101.DEF tmb-20211130_def.xml EX-101.DEF 299946
8 EX-101.LAB tmb-20211130_lab.xml EX-101.LAB 525181
9 EX-101.PRE tmb-20211130_pre.xml EX-101.PRE 448775
65 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20211130x10k_htm.xml XML 1254702
Mailing Address 366 MADISON AVE. 3RD FLOOR NEW YORK NY 10017
Business Address 366 MADISON AVE. 3RD FLOOR NEW YORK NY 10017 212-588-0022
Q BioMed Inc. (Filer) CIK: 0001596062 (see all company filings)

IRS No.: 464013793 | State of Incorp.: NV | Fiscal Year End: 1130
Type: 10-K | Act: 34 | File No.: 000-55535 | Film No.: 22690578
SIC: 2834 Pharmaceutical Preparations